GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Odyssey Group International Inc (OTCPK:ODYY) » Definitions » 10-Year ROIIC %

ODYY (Odyssey Group International) 10-Year ROIIC % : -373.95% (As of Jul. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Odyssey Group International 10-Year ROIIC %?

10-Year Return on Invested Incremental Capital (10-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 10-year. Odyssey Group International does not have enough data to calculate 10-Year ROIIC %.


Odyssey Group International 10-Year ROIIC % Historical Data

The historical data trend for Odyssey Group International's 10-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Odyssey Group International 10-Year ROIIC % Chart

Odyssey Group International Annual Data
Trend Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
10-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Odyssey Group International Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
10-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Odyssey Group International's 10-Year ROIIC %

For the Medical Devices subindustry, Odyssey Group International's 10-Year ROIIC %, along with its competitors' market caps and 10-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Odyssey Group International's 10-Year ROIIC % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Odyssey Group International's 10-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Odyssey Group International's 10-Year ROIIC % falls into.



Odyssey Group International 10-Year ROIIC % Calculation

Odyssey Group International's 10-Year ROIIC % for the quarter that ended in Jul. 2024 is calculated as:

10-Year ROIIC %=10-Year Incremental Net Operating Profit After Taxes (NOPAT)**/10-Year Incremental Invested Capital**
=( -2.14 (Jul. 2024) - (Jul. 2014) )/( 3.301 (Jul. 2024) - (Jul. 2014) )
=/
=N/A%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 10-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Odyssey Group International  (OTCPK:ODYY) 10-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Odyssey Group International 10-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Odyssey Group International's 10-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Odyssey Group International Business Description

Traded in Other Exchanges
N/A
Address
2300 West Sahara Avenue, Suite 800 - No. 4012, Las Vegas, NV, USA, 89102
Odyssey Group International Inc is a company focused on developing life-saving medical products, Odyssey's goal is to create, acquire and accumulate distinct assets, intellectual property, and technologies that provide meaningful medical solutions. The Company is focused on building and acquiring assets in areas that have an identified technological advantage, provide superior clinical utility, and have a substantial market opportunity. The company have two different technologies in the research and development stage; the CardioMap heart monitoring and screening device, and the Save a Life choking rescue device.
Executives
Erik C. Emerson other: Chief Commercial Officer 2300 WEST SAHARA AVENUE, SUITE 800 - #4012, LAS VEGAS NV 89102
Gregory W Gironda other: Chief Operating Officer 2300 WEST SAHARA AVENUE, SUITE 800 - #4012, LAS VEGAS NV 89102
Ricky Richardson director 2372 MORSE AVE., IRVINE CA 92614
Christine Farrell officer: Controller/Secretary 2372 MORSE AVE, IRVINE CA 92614
John P Gandolfo director 62 TERRACE ROAD, WAYNE NJ 07470
Jerome H Casey director 2372 MORSE AVE, IRVINE CA 92614
Jeffrey X Conroy director 2372 MORSE AVE, IRVINE CA 92614
Vanlandingham Jacob Ph.d director 2372 MORSE AVE, IRVINE CA 92614
J Michael Redmond director, officer: President/CEO 10 CANTERBURY ROAD, WINDHAM NH 03087